Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ALXN > SEC Filings for ALXN > Form 8-K on 16-Jul-2014All Recent SEC Filings




Change in Directors or Principal Officers, Financial Statements and E

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On July 16, 2014, the Board of Directors of Alexion Pharmaceuticals, Inc. increased the number of directors from 8 to 11 and appointed David R. Brennan, M. Michele Burns and Christopher J. Coughlin to Alexion's Board of Directors, effective immediately.
Mr. Brennan is expected to join the Compensation, Pharmaceutical Compliance and Quality, and Risk and Strategy Committees. Ms. Burns is expected to join the Compensation, Nominating and Corporate Governance, and Risk and Strategy Committees, serving as Chair of the Risk and Strategy Committee. Mr. Coughlin is expected to join the Audit, Nominating and Corporate Governance, and Pharmaceutical Compliance and Quality Committees.
There are no transactions and no proposed transactions between each of Mr. Brennan, Ms. Burns or Mr. Coughlin (or any member of such individual's immediate family) and Alexion (or any of its subsidiaries), and there is no arrangement or understanding between each of Mr. Brennan, Ms. Burns or Mr. Coughlin and any other person or entity pursuant to which such individual was appointed as a director of Alexion.
Each director will participate in Alexion's standard compensation plan for non-employee directors.

A copy of Alexion's press release announcing the appointments is filed as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Press Release issued by Alexion Pharmaceuticals, Inc. on July 16, 2014.

  Add ALXN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ALXN - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.